Xiao-Ming Xie Selected Research

Xiao-Ming Xie Research Topics

13	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2012
3	Neoplasms (Cancer) 01/2022 - 04/2017
2	Lymphatic Metastasis 01/2021 - 01/2013
2	Neoplasm Metastasis (Metastasis) 01/2013 - 01/2012
1	Weight Loss (Weight Reduction) 06/2022
1	Weight Gain 06/2022
1	Disease Progression 06/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Breast Carcinoma In Situ 01/2017
1	Obesity 01/2017
1	Triple Negative Breast Neoplasms 01/2013
1	Fever (Fevers) 01/2012
1	Infections 01/2012
1	Acute Coronary Syndrome 06/2006
1	Atherosclerotic Plaque (Atheroma) 06/2006

2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 11/2013
2	ORALIT (ORS)IBA 01/2017 - 01/2012
2	Estrogens (Estrogen)FDA Link 01/2014 - 11/2013
1	Indicators and Reagents (Reagents)IBA 06/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	LipidsIBA 08/2019
1	TeaIBA 08/2019
1	Chaperonin 60IBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Activating Transcription Factor 2IBA 06/2016
1	Tsg101 proteinIBA 06/2016
1	Epidermal Growth Factor (EGF)IBA 01/2014
1	Progesterone FDA LinkGeneric 01/2014
1	Biological ProductsIBA 01/2014
1	Fibroblast Growth Factor 1 (FGF-1)IBA 11/2013
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2013
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 11/2013
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2013
1	Tyrosine (L-Tyrosine)FDA Link 01/2013
1	Phenobarbital (Luminal)FDA Link 01/2012
1	InterferonsIBA 01/2012
1	Interferon-gamma (Interferon, gamma)IBA 01/2012
1	Fluvastatin FDA Link 06/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2006

3	Therapeutics 06/2022 - 01/2012
3	Radiotherapy 04/2017 - 02/2013
2	Segmental Mastectomy (Lumpectomy) 01/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 04/2017
1	Prophylactic Mastectomy 01/2017
1	Mastectomy (Mammectomy) 01/2017